Owkin Stock
Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. Their mission is to understand complex biology and derive new multimodal biomarkers through AI.
Sign up for SecondMarket™ to view the market and buy or sell Owkin Stock
Buy + SellOwkin Funding
Sign up to gain insights into Owkin funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Jun 07, 2022 | Series B | 80.00M | ||
| Dec 15, 2021 | Series B | 180.00M | ||
| May 01, 2020 | Series A | 25.00M | ||
| Apr 17, 2019 | Series A | 13.04M | ||
| May 08, 2018 | Series A | 5.00M | ||
| Feb 14, 2018 | Series A | 11.02M | ||
| Jan 16, 2018 | Series Seed | 2.10M |
See Owkin Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Owkin Stock Valuation + Share Prices
View real-time Tape D™ data on Owkin stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Owkin Management Team
Chief Marketing Officer
Darius Meadon
Director
Laurent Higueret
Director
Alex Pasteur
Director
Nicole Junkermann
Director
Jacky Abitbol
Director
Bruno Strigini
Chief Diagnostics Officer
Meriem Sefta
Chief Operating Officer
Alban de la Sablière
Chief People Officer
Mariabrisa Olivares
Director
Jérôme Pesenti
Chief Medical Officer
Vassili Soumelis
Director
Jean-Jacques Bienaime
Chief Research and Development Officer
Jean-Philippe Vert
Chief Financial Officer
Andreas Emmenegger
Director
Bruno Raillard
Co-Founder, CEO, Director
Thomas Clozel
Owkin Major Investors
Bpifrance Investissement SAS
Bristol-Myers Squibb Company
Cathay Innovation
Eight Roads Ventures
F-Prime Capital Partners
Google Ventures (GV)
MACSF
NJF Capital
Otium Capital
Plug and Play Tech Center
Sanofi Ventures
